1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period.

      Circulation
      biopsy, cardiomyopathies, complications, diagnosis, myocarditis

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Use of left ventricular (LV) endomyocardial biopsy (EMB) to investigate cardiomyopathies is currently discouraged because it is considered riskier than and as contributive as right ventricular (RV) biopsy. The aim of our study is to report our experience with this option and to discuss its advantages and disadvantages.

          Related collections

          Author and article information

          Journal
          24004501
          10.1161/CIRCULATIONAHA.13.001414

          biopsy,cardiomyopathies,complications,diagnosis,myocarditis
          biopsy, cardiomyopathies, complications, diagnosis, myocarditis

          Comments

          Comment on this article

          scite_